1. Panel 13: Complex International Science, Technology and Innovation Partnerships: Lessons for Canada Pierre Bilodeau, PhD Chief Operating Officer ISTPCanada How to Maximize Benefits to Canada from CISTIPs?

2. Canadian CISTIP Environment

3. Canada`s International STI Policy 1970 2015 1986:Japan 1992: Israel 2008: Brazil, China & India 1996: European Community 1971 : Germany and Belgium 2011: Russia 2010: Sweden2012: UK1983: Algeria CIIRDF: $1M/yr ISTPP1: $20M/5 yrs ISTPP2: $20M/5 yrs Canada joins EUREKA CIESTF: $5M/3yrs 2014: Korea

4. Trade-Driven CISTIP Programs ISTPPEUREKA Started2005 (1994, CIIRDF) Started 1985 – Canada joined as associate member in June 2012 Host Department Foreign Affairs, Trade and Development (DFATD) National Research Council (NRC) Target Countries Israel, Brazil, China, India EUREKA Members (41 full members, 2 NIPs, 3 Associated Countries) Delivery mechanism Not for profit, arm length organisations (CIIRDF, ISTPCanada) NRC-IRAP, other Innovation actors supported by a national advisory committee Funding $20 million/5 years (2010- 2015) Existing national sources including NRC-IRAP for eligible SMEs

5. ISTPP Objectives  Encourage domestic competitiveness through the transfer of technology and knowledge;  Foster international S&T partnerships and collaborative research with an emphasis on industrial outcomes;  Accelerate the commercialization of R&D, with a focus on small and medium-sized enterprises;  Access international technologies for Canadian enterprises;  Promote Canadian R&D capacity and Canada as a destination for foreign technology-based investments;  Encourage the mobility of researchers and to promote Canada as a career destination for foreign talent; and  Strengthen overall bilateral S&T relations.

6. ISTPP Governance (Canada-India) Joint committee

7. ISTPP Targeted Technology Areas CategoryBrazilChinaIndia Energy, Material, Transportation Energy – specifically renewable energy and fuel cells Energy Alternate energy and sustainable environmental technologies, aerospace Health, and Life Sciences Life sciences – specifically bio- health and medical technology Health & life sciences biotechnology, agriculture, foods and bio-products Biotechnology, health research and medical devices Natural Resources, Environment Environment Earth sciences and disaster management ICT ICT; including Software ICT

8. ISTPP Results/Outcomes

9. ISTPP Performance Measurement Key Performance Issues Matchmaking Collaborative R&D projects Targeted technology areas Contribution to the economic position of stakeholders Contribution to the creation of an innovative workforce

10. Additional ISTPP Achievements  A national innovation agency dedicated to CISTIPs;  Program integration of national U-I collaborations with international B2B partnerships;  Federal-provincial collaborations on CISTIPs;  Working relationships and track records with key trading partner countries;

11. ISTPP Summative Evaluation (2010)  Continue to advocate for a significant increase in the level of funding to support ISTPP;  Ensure that formal governance mechanisms are in place to provide strategic guidance on technology areas of common interest;  Reassess the risks of entrusting an "arms–length" delivery organization with a leadership role in the funding of partnership development activities.  Conduct an international benchmarking study to determine reasonable performance expectations for ISTPP. Source: http://www.international.gc.ca/about-a_propos/oig- big/2010/evaluation/istpp_ppist10.aspx?lang=enghttp://www.international.gc.ca/about-a_propos/oig- big/2010/evaluation/istpp_ppist10.aspx?lang=eng

12. How to Maximize Benefits to Canada from CISTIPs

13. Gaps & Opportunities  We must integrate CISTIP policy instruments with Canadian technological & commercial strengths;  We must determine which countries can help Canada advance which priority areas and how;  We need to better align CISTIP resources between federal and provincial governments;

14. Conclusion «For Canada to succeed in CISTIP, we must first nurture and improve national cohesion and collaboration among stakeholders.»

15. Thank you! Pierre Bilodeau, PhD Chief Operating Officer ISTPCanada